Responder analysis of patient-reported outcomes measurement information system (PROMIS) physical function (PF) and worst stiffness among patients with tenosynovial giant cell tumors (TGCT) in the ENLIVEN study.

William D. Tap,Rebecca M. Speck,Xin Ye,Emanuela Palmerini,Silvia Stacchiotti,Jayesh Desai,Andrew J. Wagner,Thierry Alcindor,Kristen N. Ganjoo,Javier Martin Broto,Qiang Wang,Dale Shuster,Heather L. Gelhorn,Hans Gelderblom

Responder analysis of patient-reported outcomes measurement information system (PROMIS) physical function (PF) and worst stiffness among patients with tenosynovial giant cell tumors (TGCT) in the ENLIVEN study.

2019

William D. Tap
Rebecca M. Speck
Xin Ye
Emanuela Palmerini
Silvia Stacchiotti
Jayesh Desai
Andrew J. Wagner
Thierry Alcindor
Kristen N. Ganjoo
Javier Martin Broto
Qiang Wang
Dale Shuster
Heather L. Gelhorn
Hans Gelderblom

e18236Background: The double-blind, randomized, placebo-controlled phase 3 ENLIVEN study in TGCT demonstrated a significant tumor response at week 25 by RECIST for pexidartinib (39% vs. 0% for plac...

Keywords:

Patient-Reported Outcomes Measurement Information System
Giant Cell Tumors
Physical therapy
Radiology
Medicine
Pexidartinib
physical function
tumor response
Oncology
Internal medicine
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations